Oxaceprol (600 mg) Sustained Release Tablets Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Oxaceprol (600 mg) Sustained Release Tablets Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Oxaceprol SR Once-Daily
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Oxaceprol (600 mg) Sustained Release Tablets Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Oxaceprol (600 mg) Sustained Release Tablets Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Oxaceprol (600 mg) Sustained Release Tablets Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Oxaceprol (600 mg) Sustained Release Tablets formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Chronic OA maintenance (once-daily)
- Spondylosis long-term therapy
- Joint maintenance in elderly
Mechanism of Action
Same as Oxacure-200 with sustained release formulation.
Dosage & Administration
- Adults: 1 tablet once daily.
Side Effects
- Mild GI upset, occasional rash.
Contraindications
- Hypersensitivity, severe hepatic disease.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Oxaceprol (600 mg) Sustained Release Tablets Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 1 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Oxaceprol (600 mg) Sustained Release Tablets Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Oxaceprol (600 mg) Sustained Release Tablets Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Oxaceprol (600 mg) Sustained Release Tablets Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Oxaceprol (600 mg) Sustained Release Tablets Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Oxaceprol (600 mg) Sustained Release Tablets Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Oxaceprol (600 mg) Sustained Release Tablets Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Oxaceprol (600 mg) Sustained Release Tablets Tablet?
Available pack sizes include: 10 x 1 x 10 (Alu-Alu).
What is the MRP / trade price for Oxaceprol (600 mg) Sustained Release Tablets Tablet?
MRPs range from ₹6890 to ₹6890 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Oxaceprol (600 mg) Sustained Release Tablets Tablet?